J&J decides not to conduct trials in India for its COVID-19 vaccine | Inquirer News

J&J decides not to conduct trials in India for its COVID-19 vaccine

/ 02:46 PM June 29, 2021

Johnson & Johnson

Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS FILE PHOTO

Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India, the Economic Times reported on Tuesday, citing a company spokesperson.

While J&J had sought approval for conducting bridging trials in the country, the U.S.-based drugmaker said it wouldn’t have to do that now since India has scrapped that requirement, according to the report. (https://bit.ly/3h2x358)

Article continues after this advertisement

The company is exploring how to accelerate the availability of its vaccine in India, the Economic Times said.

J&J did not immediately respond to a Reuters request for comment.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: India

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.